Heghine Khachatryan: Best-Practice Recommendations for Implementing Shared Decision-Making in Hemophilia Care
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared European Association for Haemophilia and Allied Disorders‘ post on LinkedIn, adding:
“Shared decision-making is becoming a cornerstone of modern hemophilia care.
A recent collaborative initiative led by the European Association for Haemophilia and Allied Disorders (EAHAD), together with the World Federation of Hemophilia (WFH) and the European Haemophilia Consortium (EHC), highlights best-practice recommendations for implementing shared decision-making in clinical practice.
This approach recognizes that optimal hemophilia management goes beyond clinical protocols.
It requires meaningful collaboration between physicians, patients, and caregivers to ensure that treatment choices align with individual needs, lifestyles, and long-term health goals.
As therapeutic options expand—from factor replacement therapies to non-factor treatments such as emicizumab—the importance of informed dialogue and patient engagement becomes even more critical.
Strengthening shared decision-making helps improve adherence, treatment satisfaction, and overall outcomes for people living with hemophilia.
Valuable insights for clinicians, patient organizations, and policymakers working to improve hemophilia care worldwide.”
European Association for Haemophilia and Allied Disorders shared a post on LinkedIn:
“EAHAD, together with the World Federation of Hemophilia and the EHC – European Haemophilia Consortium co-led a multi-stakeholder project to develop best practice statements for shared decision-making (SDM) in haemophilia.”
Title: Implementing Shared Decision-Making in Haemophilia Care: Best Practice Recommendations From a Western European Multi-Stakeholder Delphi Process
Authors: Donna Coffin, Robert Klamroth, Miguel Crato, Elizabeth Clearfield, Cedric Hermans, Karine Kocharyan, Maria Elisa Mancuso, Salome Mekhuzla, Thomas Sannié, Mark W. Skinner, Glenn F. Pierce
Read the Full Article on Haemophilia.
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Sep 1, 2026, 17:04Hugo R Lara-Martinez: Recognizing HLH After Immune Checkpoint Inhibitor Therapy
-
Sep 1, 2026, 16:50Heghine Khachatryan: When to Test for Thrombophilia After VTE
-
Sep 1, 2026, 16:41Axel Diederichsen: Can Vitamin K2 and Vitamin D3 Slow the Progression of Severe Coronary Artery Calcification?
-
Sep 1, 2026, 16:15Sangeeta Pathak: The Bombay Blood Group as a Very Rare Phenotype
-
Sep 1, 2026, 16:14The Ecuador 2026 National Conference on Coagulation Disorders – WFH
-
Sep 1, 2026, 15:54Alejandro González Veliz: Can Treating Tricuspid Regurgitation Change Outcomes?
-
Sep 1, 2026, 15:51Ingo Ahrens: Another Step Forward in Catheter-Directed Thrombolysis for Acute PE
-
Sep 1, 2026, 15:20Sohail Khan: What Comes After IV Thrombolysis
-
Sep 1, 2026, 15:09Harish Chowdary Gorrepati: The HALT Paradox After TAV